Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.

Hans-Joachim Schmoll; Lars H Lindner; Peter Reichardt; Klaus Heißner; Hans-Georg Kopp; Torsten Kessler; Regine Mayer-Steinacker; Jörn Rüssel; Gerlinde Egerer; Martina Crysandt; Bernd Kasper; Dietger Niederwieser; Annegret Kunitz; Ekkehard Eigendorff; Iver Petersen; Jörg Steighardt; Franziska Cygon; Fabian Meinert; Alexander Stein

doi:10.1001/jamaoncol.2020.6564

Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.

Hans-Joachim Schmoll
, Lars H Lindner
, Peter Reichardt
, Klaus Heißner (Co-Autor/-in)
, Hans-Georg Kopp
, Torsten Kessler
, Regine Mayer-Steinacker
, Jörn Rüssel
, Gerlinde Egerer
, Martina Crysandt
, Bernd Kasper
, Dietger Niederwieser
, Annegret Kunitz
, Ekkehard Eigendorff
, Iver Petersen
, Jörg Steighardt
, Franziska Cygon
, Fabian Meinert
, Alexander Stein

Universitätsklinik für Innere Medizin 3 - Pneumologie, Allergologie, Schlafmedizin

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

29 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	255-262
Fachzeitschrift	JAMA ONCOLOGY
Jahrgang	7
Ausgabenummer	2
DOIs	https://doi.org/10.1001/jamaoncol.2020.6564
Publikationsstatus	Veröffentlicht - 2021

Zugriff auf Dokument

10.1001/jamaoncol.2020.6564

Dieses zitieren

Schmoll, H.-J., Lindner, L. H., Reichardt, P., Heißner, K., Kopp, H.-G., Kessler, T., Mayer-Steinacker, R., Rüssel, J., Egerer, G., Crysandt, M., Kasper, B., Niederwieser, D., Kunitz, A., Eigendorff, E., Petersen, I., Steighardt, J., Cygon, F., Meinert, F., & Stein, A. (2021). Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial. JAMA ONCOLOGY, 7(2), 255-262. https://doi.org/10.1001/jamaoncol.2020.6564

@article{55f4f8ea23534236b6e1399a6e16a800,

title = "Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.",

keywords = "II TRIAL, LEIOMYOSARCOMAS, CHEMOTHERAPY, MULTICENTER, DOCETAXEL, EORTC",

author = "Hans-Joachim Schmoll and Lindner, \{Lars H\} and Peter Reichardt and Klaus Hei{\ss}ner and Hans-Georg Kopp and Torsten Kessler and Regine Mayer-Steinacker and J{\"o}rn R{\"u}ssel and Gerlinde Egerer and Martina Crysandt and Bernd Kasper and Dietger Niederwieser and Annegret Kunitz and Ekkehard Eigendorff and Iver Petersen and J{\"o}rg Steighardt and Franziska Cygon and Fabian Meinert and Alexander Stein",

note = "Hei{\ss}ner: Paracelsus Medical University, Nuremberg, Germany.",

year = "2021",

doi = "10.1001/jamaoncol.2020.6564",

language = "English",

volume = "7",

pages = "255--262",

journal = "JAMA ONCOLOGY",

issn = "2374-2437",

number = "2",

}

Schmoll, H-J, Lindner, LH, Reichardt, P, Heißner, K, Kopp, H-G, Kessler, T, Mayer-Steinacker, R, Rüssel, J, Egerer, G, Crysandt, M, Kasper, B, Niederwieser, D, Kunitz, A, Eigendorff, E, Petersen, I, Steighardt, J, Cygon, F, Meinert, F & Stein, A 2021, 'Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.', JAMA ONCOLOGY, Jg. 7, Nr. 2, S. 255-262. https://doi.org/10.1001/jamaoncol.2020.6564

Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial. / Schmoll, Hans-Joachim; Lindner, Lars H; Reichardt, Peter et al.
in: JAMA ONCOLOGY, Jahrgang 7, Nr. 2, 2021, S. 255-262.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.

AU - Schmoll, Hans-Joachim

AU - Lindner, Lars H

AU - Reichardt, Peter

AU - Heißner, Klaus

AU - Kopp, Hans-Georg

AU - Kessler, Torsten

AU - Mayer-Steinacker, Regine

AU - Rüssel, Jörn

AU - Egerer, Gerlinde

AU - Crysandt, Martina

AU - Kasper, Bernd

AU - Niederwieser, Dietger

AU - Kunitz, Annegret

AU - Eigendorff, Ekkehard

AU - Petersen, Iver

AU - Steighardt, Jörg

AU - Cygon, Franziska

AU - Meinert, Fabian

AU - Stein, Alexander

N1 - Heißner: Paracelsus Medical University, Nuremberg, Germany.

PY - 2021

Y1 - 2021

KW - II TRIAL

KW - LEIOMYOSARCOMAS

KW - CHEMOTHERAPY

KW - MULTICENTER

KW - DOCETAXEL

KW - EORTC

U2 - 10.1001/jamaoncol.2020.6564

DO - 10.1001/jamaoncol.2020.6564

M3 - Original Article

C2 - 33355646

SN - 2374-2437

VL - 7

SP - 255

EP - 262

JO - JAMA ONCOLOGY

JF - JAMA ONCOLOGY

IS - 2

ER -